The weekly litigation news digest is live. Subscribe now
Pharmaceutical Composition Comprising Udenafil - EP4005556
The patent EP4005556 was granted to Corepharm BIO on Feb 19, 2025. The application was filed on Jul 24, 2020 under application number EP20848224A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4005556
- Application Number
- EP20848224A
- Filing Date
- Jul 24, 2020
- Status
- Granted And Under Opposition
- Jan 17, 2025
- Publication Date
- Feb 19, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (17) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents